77 related articles for article (PubMed ID: 19876009)
1. Neutral aminopeptidase and dipeptidyl peptidase IV activities in plasma of monosodium glutamate obese and food-deprived rats.
Alponti RF; Silveira PF
Obesity (Silver Spring); 2010 Jul; 18(7):1312-7. PubMed ID: 19876009
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV in the hypothalamus and hippocampus of monosodium glutamate obese and food-deprived rats.
Alponti RF; Frezzatti R; Barone JM; Alegre Vde S; Silveira PF
Metabolism; 2011 Feb; 60(2):234-42. PubMed ID: 20153005
[TBL] [Abstract][Full Text] [Related]
3. APM/CD13 and FOS in the hypothalamus of monosodium glutamate obese and food deprived rats.
Alponti RF; Nogueira MI; Mendes MT; de Abreu C; Silveira PF
Regul Pept; 2011 Jan; 166(1-3):98-104. PubMed ID: 20851150
[TBL] [Abstract][Full Text] [Related]
4. Neutral aminopeptidase and dipeptidyl peptidase IV in the development of collagen II-induced arthritis.
Yamasaki SC; Murari-do-Nascimento S; Silveira PF
Regul Pept; 2012 Jan; 173(1-3):47-54. PubMed ID: 21982785
[TBL] [Abstract][Full Text] [Related]
5. Effect of food restriction on energy expenditure of monosodium glutamate-induced obese rats.
Luz J; Pasin VP; Silva DJ; Zemdegs JC; Amaral LS; Affonso-Silva SM
Ann Nutr Metab; 2010; 56(1):31-5. PubMed ID: 20016145
[TBL] [Abstract][Full Text] [Related]
6. Effect of adrenalectomy on the activity of small intestine enzymes in monosodium glutamate obese rats.
Mozes S; Sefcíkov Z; Lenhardt L; Racek L
Physiol Res; 2004; 53(4):415-22. PubMed ID: 15312001
[TBL] [Abstract][Full Text] [Related]
7. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats.
Dolnikoff M; Martín-Hidalgo A; Machado UF; Lima FB; Herrera E
Int J Obes Relat Metab Disord; 2001 Mar; 25(3):426-33. PubMed ID: 11319642
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats.
de Mello MA; de Souza CT; Braga LR; dos Santos JW; Ribeiro IA; Gobatto CA
Physiol Chem Phys Med NMR; 2001; 33(1):63-71. PubMed ID: 11758736
[TBL] [Abstract][Full Text] [Related]
9. Prolonged but not short negative energy condition restored corticoadrenal leptin sensitivity in the hypothalamic obese rat.
Perello M; Castrogiovanni D; Giovambattista A; Gaillard RC; Spinedi E
Neuroendocrinology; 2009; 89(3):276-87. PubMed ID: 19141989
[TBL] [Abstract][Full Text] [Related]
10. Vagotomy reduces obesity in MSG-treated rats.
Balbo SL; Mathias PC; Bonfleur ML; Alves HF; Siroti FJ; Monteiro OG; Ribeiro FB; Souza AC
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):291-6. PubMed ID: 11958282
[TBL] [Abstract][Full Text] [Related]
11. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats.
Diniz YS; Faine LA; Galhardi CM; Rodrigues HG; Ebaid GX; Burneiko RC; Cicogna AC; Novelli EL
Nutrition; 2005 Jun; 21(6):749-55. PubMed ID: 15925301
[TBL] [Abstract][Full Text] [Related]
12. Obese patients have higher circulating protein levels of dipeptidyl peptidase IV.
Stengel A; Goebel-Stengel M; Teuffel P; Hofmann T; Buße P; Kobelt P; Rose M; Klapp BF
Peptides; 2014 Nov; 61():75-82. PubMed ID: 25219943
[TBL] [Abstract][Full Text] [Related]
13. Effect of fasting and refeeding on duodenal alkaline phosphatase activity in monosodium glutamate obese rats.
Racek L; Lenhardt L; Mozes S
Physiol Res; 2001; 50(4):365-72. PubMed ID: 11551142
[TBL] [Abstract][Full Text] [Related]
14. Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats.
Franco CCS; Prates KV; Previate C; Moraes AMP; Matiusso CCI; Miranda RA; de Oliveira JC; Tófolo LP; Martins IP; Barella LF; Ribeiro TA; Malta A; Pavanello A; Francisco FA; Gomes RM; Alves VS; Moreira VM; Rigo KP; Almeida DL; de Sant Anna JR; Prado MAAC; Mathias PCF
Endocrine; 2017 May; 56(2):346-356. PubMed ID: 28233096
[TBL] [Abstract][Full Text] [Related]
15. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
[TBL] [Abstract][Full Text] [Related]
16. Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats.
Cunha NV; de Abreu SB; Panis C; Grassiolli S; Guarnier FA; Cecchini R; Mazzuco TL; Pinge-Filho P; Martins-Pinge MC
Life Sci; 2010 Sep; 87(11-12):375-81. PubMed ID: 20688085
[TBL] [Abstract][Full Text] [Related]
17. MSG intake suppresses weight gain, fat deposition, and plasma leptin levels in male Sprague-Dawley rats.
Kondoh T; Torii K
Physiol Behav; 2008 Sep; 95(1-2):135-44. PubMed ID: 18559279
[TBL] [Abstract][Full Text] [Related]
18. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
[TBL] [Abstract][Full Text] [Related]
19. Nitrogen metabolism in obesity induced by monosodium-L-glutamate in rats.
Betrán MA; Estornell E; Barber T; Cabo J
Int J Obes Relat Metab Disord; 1992 Aug; 16(8):555-64. PubMed ID: 1326485
[TBL] [Abstract][Full Text] [Related]
20. Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose- and monosodium glutamate-treated mice.
Machado UF; Shimizu Y; Saito M
Horm Metab Res; 1993 Sep; 25(9):462-5. PubMed ID: 8225198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
